Replies to post #241108 on Amarin Corp Plc (AMRN)

[KCSVEN]

It’s a nothing burger. Amarin has sales projections based on no generics until 2029, billions of dollars per year down the road they say. Should the judge hold that against them? The generics are planning on making Vascepa, that’s why Amarin is suing them. So they are projecting sales like Amarin, no different, if you read Amarin filings the risks are there including generics suit, same would be for Hikma.

[marjac]

The Judge would absolutely care. Not only is the material relevant on the underlying claims, it is a blow to Defendants' credibility. Amarin's attorneys need to immediately file a motion to get this newly discovered evidence admitted, and then aggressively run with it as far as they can.